top of page
ChatGPT Image Jun 16, 2026 at 10_37_48 PM.png

PharmaQuiz

Lurasidone

This section provides a selection of diverse resources intended to support your preparation for and completion of the quiz. The materials may include scientific articles, official reports, practice guidelines, and other relevant documents offering complementary perspectives. Engaging with these resources prior to or during the quiz will help you deepen your understanding of the subject matter, strengthen your analytical approach, and enhance the overall quality of your learning process.

Towards Full Recovery with Lurasidone: Effective Doses in the Treatment of Agitation, Affective, Positive, and Cognitive Symptoms in Schizophrenia and of Dual Psychosis

Guarro Carreras MT, Jiménez Suárez L, et al. Drugs Context. 2024;13:2024-4-4.

Lurasidone for Treating Schizophrenia and Bipolar Depression: A Review of Its Efficacy

Tarzian M, et al. Cureus. 2023;15(4):e38071.

Lurasidone in adolescents and adults with schizophrenia

Fiorillo A, et al. Expert Opin Pharmacother. 2022;23(16):1801-1818.

Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review

Ricci V, De Berardis D, Maina G. Healthcare. 2024;12:339.

Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy

Miura I, et al. Drug Des Devel Ther. 2023;17:3023-3031.

A network meta-analysis of the dose-response effects of lurasidone on acute schizophrenia

Srisurapanont M, et al. Sci Rep. 2021;11:5571.

Lurasidone Compared to Other Atypical Antipsychotic Monotherapies for Adolescent Schizophrenia

Arango C, Ng-Mak D, Finn E, et al. Eur Child Adolesc Psychiatry. 2020;29:1195-1205.

Lurasidone for the treatment of schizophrenia in adult and paediatric populations

Guilera T, et al. Drugs Context. 2023;12:2022-10-1.

Efficacy and Safety of Lurasidone Versus Placebo as Adjunctive to Mood Stabilizers in Bipolar I Depression

Wang H, Xiao L, Wang HL, Wang GH. J Affect Disord. 2020;264:227-233.

Efficacy and acceptability of lurasidone for bipolar depression

Lin YW, et al. BMJ Ment Health. 2024;27:1-10.

Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel

Bernardo M, Díaz Marsá M, González-Pinto A, et al. Neurol Ther. 2025;14:85-98.

Lurasidone: A Clinical Overview

Kane JM. J Clin Psychiatry. 2011;72(Suppl 1):24-28.

CME Certificate

You can download the continuing education certificate here and open it with the password.
You can then enter your name and save or print the certificate.

 

© 2026 Swiss Society of Addiction Medicine

 

bottom of page